Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Long-Term Investments Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Long-Term Investments
kr196m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Long-Term Investments
kr837m
CAGR 3-Years
193%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Long-Term Investments
€20.6m
CAGR 3-Years
-47%
CAGR 5-Years
4%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Long-Term Investments
kr144k
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Long-Term Investments
kr1.3m
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
8%

See Also

What is Genmab A/S's Long-Term Investments?
Long-Term Investments
196m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Long-Term Investments amounts to 196m DKK.

What is Genmab A/S's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-36%

Over the last year, the Long-Term Investments growth was 7%. The average annual Long-Term Investments growth rates for Genmab A/S have been -36% over the past three years .

Back to Top